ATP1A1-linked diseases require a malfunctioning protein product from one allele
K. Spontarelli, V. C. Young, R. Sweazey, A. Padro, J. Lee, T. Bueso, R. M. Hernandez, J. Kim, A. Katz, F. Rossignol, C. Turner, C. M. Wilczewski, G. Maxwell, M. Holmgren, J. D. Bailoo, , P. Artigas
The paper investigates whether haploinsufficiency from protein-null ATP1A1 variants causes disease, finding that Atp1a1+/- mice are phenotypically normal and a human with a null variant shows no disease features.
bioRxiv · Mar 5, 2023Physiology